Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07479433 · ClinicalTrials.gov registry record
The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI
A clinical trial of Coronary Artery Disease (CAD), sponsored by HeartFlow.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT07479433 is a study of Coronary Artery Disease (CAD) that is actively recruiting participants, run by HeartFlow. The registered enrollment target is 5,000 participants, above the 144-participant average among 5 other Coronary Artery Disease (CAD) trials with a reported enrollment target (3372% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07479433, a study of Coronary Artery Disease (CAD), is actively recruiting participants, sponsored by HeartFlow.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of Heartflow's NAVIGATE-PCI Registry is to collect observational data about the management of patients before and after deployment of Heartflow's PCI Navigator.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Heartflow PCI Navigator
Study Locations (1)
Georgia
- Wellstar Health System - Marietta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2026-03-11 |
| Est. Completion | 2032-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07479433
The ClinicalTrials.gov registry entry for NCT07479433 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 144-participant average among 5 other Coronary Artery Disease (CAD) trials with a reported enrollment target (3372% higher). The listed sponsor is HeartFlow, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Artery Disease (CAD) appearing as the primary indexed condition, and to 1 intervention - of which Heartflow PCI Navigator is the first listed.
NCT07479433 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT07479433 about?
NCT07479433 is a clinical study titled "The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI". The objective of Heartflow's NAVIGATE-PCI Registry is to collect observational data about the management of patients before and after deployment of Heartflow's PCI Navigator.
What is the current status of trial NCT07479433?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2026-03-11. Estimated completion is 2032-12-31.
What conditions does trial NCT07479433 study?
This clinical trial studies the following conditions: Coronary Artery Disease (CAD).
What interventions are being tested in trial NCT07479433?
The interventions under investigation include: Heartflow PCI Navigator (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07479433?
This trial is sponsored by HeartFlow, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07479433 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease (CAD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Using CTA Measures to Define Cardiac Risk In NFL Alumni
RECRUITING
-
Beating the Blues for Your Heart
COMPLETED · Phase 2
-
A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population
COMPLETED
-
Endothelial Progenitor Cells and Nitric Oxide in Cardiac Rehabilitation Program Participants
COMPLETED
-
Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.